RUNX3 protein is overexpressed in human basal cell carcinomas

Oncogene

Volumn 25, Issue 58, 2006, Pages 7646-7649

  Salto Tellez, M ^a,b   Peh, B K ^b   Ito, K ^b,d   Tan, S H ^c   Chong, P Y ^a,b   Han, H C ^b   Tada, K ^b   Ong, W Y ^c   Soong, R ^a,b   Voon, D C ^d   Ito, Y ^b,d  

^a NATIONAL UNIVERSITY HOSPITAL   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL SKIN CENTRE   (Singapore)

^d INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

catenin; Basal cell carcinoma; RUNX3; Sonic Hedgehog

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR RUNX3; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

ARTICLE; BASAL CELL CARCINOMA; CANCER CELL; CARCINOGENESIS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEREGULATION; DNA SEQUENCE; GENE CONSTRUCT; GENE MUTATION; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SKIN CULTURE; TISSUE MICROARRAY; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CARCINOMA, BASAL CELL; CASE-CONTROL STUDIES; CELL MEMBRANE; CORE BINDING FACTOR ALPHA 3 SUBUNIT; HEDGEHOG PROTEINS; HUMANS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; SKIN; SKIN NEOPLASMS; WNT PROTEINS;

ERINACEIDAE;

EID: 33845513110     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209739     Document Type: Article

References (36)

1. Andl T, Reddy ST, Gaddapara T, Millar SE. (2002). Dev Cell 2: 643-653.
2. Bae SC, Choi JK. (2004). Oncogene 23: 4336-4340.
3. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R et al. (1996). Nature 382: 638-642.
4. Blyth K, Cameron ER, Neil JC. (2005). Nat Rev Cancer 5: 376-387.
5. Boonchai W, Walsh M, Cummings M, Chenevix-Trench G. (2000). Arch Dermatol 136: 937-938.
6. Cameron ER, Neil JC. (2004). Oncogene 23: 4308-4314.
7. Chan EF, Gat U, McNiff JM, Fuchs E. (1999). Nat Genet 21: 410-413.
8. Chen YG, Meng AM. (2004). Cell Res 14: 441-449.
9. Dahmane N, Lee J, Robins P, Heller P, Ruiz i Altaba A. (1997). Nature 389: 876-881.
10. Daya-Grosjean L, Couve-Privat S. (2005). Cancer Lett 225: 181-192.
11. El-Bahrawy M, El-Masry N, Alison M, Poulsom R, Fallowfield M. (2003). Br J Dermatol 148: 964-970.
12. Gianakopoulos PJ, Skerjanc IS. (2005). J Biol Chem 280: 21022-21028.
13. Goodrich LV, Johnson RL, Milenkovic L, McMahon JA, Scott MP. (1996). Genes Dev 10: 301-312.
14. Gregorieff A, Clevers H. (2005). Genes Dev 19: 877-890.
15. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. (1996). Mech Dev 59: 3-10.
16. Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H et al. (2005). Cancer Res 65: 7743-7750.
17. Ito Y, Miyazono K. (2003). Curr Opin Genet Dev 13: 43-47.
18. Kawai S, Sugiura T. (2001). Bone 29: 54-61.
19. Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL et al. (2005). Cancer Res 65: 9347-9354.
20. Ku JL, Kang SB, Shin YK, Kang HC, Hong SH, Kim IJ et al. (2004). Oncogene 23: 6736-6742.
21. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ et al. (2002). Cell 109: 113-124.
22. Logan CY, Nusse R. (2004). Annu Rev Cell Dev Biol 20: 781-810.
23. Marigo V, Tabin CJ. (1996). Proc Natl Acad Sci USA 93: 9346-9351.
24. Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y et al. (2005). Liver Int 25: 380-388.
25. Reddy S, Andl T, Bagasra A, Lu MM, Epstein DJ, Morrisey EE et al. (2001). Mech Dev 107: 69-82.
26. Rubin AI, Chen EH, Ratner D. (2005). N Engl J Med 353: 2262-2269.
27. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. (1997). Science 275: 1790-1792.
28. Saldanha G, Ghura V, Potter L, Fletcher A. (2004). Br J Dermatol 151: 157-164.
29. Salto-Tellez M, Lee SC, Chiu LL, Lee CK, Yong MC, Koay ES. (2004). Clin Chem 50: 1082-1086.
30. Unden AB, Zaphiropoulos PG, Bruce K, Toftgard R, Stahle-Backdahl M. (1997). Cancer Res 57: 2336-2340.
31. van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y et al. (2004). Oncogene 23: 4209-4210.
32. Weeraratna AT. (2005). Cancer Metast Rev 24: 237-250.
33. Yamazaki F, Aragane Y, Kawada A, Tezuka T. (2001). Br J Dermatol 145: 771-777.
34. Yanada M, Yaoi T, Shimada J, Sakakura C, Nishimura M, Ito K et al. (2005). Oncol Rep 14: 817-822.
35. Yanagida M, Osato M, Yamashita N, Liqun H, Jacob B, Wu F et al. (2005). Oncogene 24: 4477-4485.
36. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA et al. (1993). Proc Natl Acad Sci USA 90: 4216-4220.